Understanding how MCS is identified, what care looks like, and how to navigate a system that is still catching up. There is no single laboratory test that definitively diagnoses MCS. This page explains the diagnostic process, available care resources, and what to expect.
What Is MCS
Multiple Chemical Sensitivity (MCS) is a chronic health condition and a recognized disability nationally and internationally. It develops in response to repeated low-level chemical exposures or a significant single exposure, after which a person experiences symptoms when exposed to chemicals at levels others may tolerate.
It is triggered by exposure to volatile organic compounds (VOCs) and other chemicals commonly found in:
MCS is not a psychological condition. It is a physiological response to chemical exposures.
Confirmed by Ontario MOHLTC expert consensus (2018). Unrebutted in the literature for over two decades.
Watch
Produced by the ECRoB research project in partnership with ASEQ-EHAQ. Captioned.
Common Triggers
For people living with MCS, exposure to triggering substances reliably results in reactions. Triggers differ between individuals, but continued exposure increases sensitization — broadening the range of substances that cause harm over time.
Sensitization is a process in which repeated or sustained exposure to triggering chemicals lowers the threshold at which reactions occur. Over time, lower levels — and a wider range of substances — can provoke symptoms. In some cases, sensitivities caused by one substance lead to reactions to other, chemically unrelated products, including foods and smoke. This is why reducing exposure early and consistently matters.
Symptoms
MCS produces reactions across multiple body systems. Symptoms vary between individuals, may change over time, and often intensify with continued exposure. People with MCS also have a higher incidence of comorbid chronic conditions compared to the general population.
Symptoms can differ between individuals but commonly involve multiple body systems. If you recognize these patterns, speak with a healthcare provider.
Who Is Affected
Multiple Chemical Sensitivity (MCS) affects people across all ages, genders, and communities. It touches the full spectrum of disabilities and every vulnerable population.
Over the past 20 years, Canada's general population grew by approximately 24%. During the same period, the population of Canadians living with MCS grew by more than 100%.
Source: Statistics Canada, Canadian Community Health Survey (CCHS)
Recognition and History
Recognition of MCS has grown steadily across clinical, legal, and policy frameworks — directly supporting access to accommodation, care, and rights-based protections.
MCS in Canada — The Data
The Broader Impact
Like many people living with disabilities in Canada, people with Multiple Chemical Sensitivity (MCS) report systemic social and economic inequality. The condition is frequently not accommodated, and the consequences are severe.
"The outcome for a person with MCS is strongly shaped by the choices and actions of the people, systems, and environments around them. Appropriate recognition, care, and accommodation can make an enormous difference."
Lived Experience
I stopped being able to go to the grocery store. The cleaning products aisle alone would put me in bed for three days.
My employer thought I was making it up. It took years, a diagnosis, and a human rights complaint before anything changed.
Breathing in perfume is like breathing in pure chlorine. It is not the same as simply finding the scent unpleasant. That is the problem — the confusion between the two.
Resources
"Everyone deserves the right to know."